Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · May 03, 2022

Safety, Pharmacokinetics, and Efficacy of Inhaled Apomorphine in Patients with PD During Morning OFF Periods

Movement Disorders: Official Journal of the Movement Disorder Society


Additional Info

Movement Disorders: Official Journal of the Movement Disorder Society
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009
Mov. Disord. 2022 Apr 01;37(4)790-798, E Thijssen, J den Heijer, D Puibert, L Moss, M Lei, D Hasegawa, K Keum, K Mochel, M Ezzeldin Sharaf, T Alfredson, W Zeng, E van Brummelen, T Naranda, GJ Groeneveld

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading